Evolus EOLS 深 滬
已收盤 08-07 16:00:00 美东时间
7.59
+0.180
+2.43%
華盛通- 最 高7.80
- 今 開7.28
- 成交量 163.20万股
- 最 低 7.21
- 昨 收 7.41
- 總市值 5.00亿
- 52周最高 7.95
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 3.86
- 委 比 97.55%
- 總股本 6585.48万
- 歷史最高 39.50
- 量 比 1.37
- 振 幅 7.96%
- 歷史最低 2.85
- 每 手 1
- 風險率 1.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Evolus Q2 EPS $(0.12), Sales $84.084M Beat $81.603M Estimate
Evolus (NASDAQ:EOLS) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.13) by 0 percent. This is a 47.83 percent increase over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $84.084 million which beat ...
08-06 04:28
Evolus Raises FY2026 Sales Guidance from $327.000M-$337.000M to $330.000M-$337.000M vs $330.445M Est
Evolus (NASDAQ:EOLS) raises FY2026 sales outlook from $327.000 million-$337.000 million to $330.000 million-$337.000 million vs $330.445 million estimate.
08-06 04:09
Evolus Expands Estyme Aesthetic Portfolio into New Markets
The latest update is out from Evolus ( ($EOLS) ). On August 3, 2026, Evolus Pha...
08-04 21:52
Evolus Secures U.S. Profhilo Distribution Agreement
Evolus ( ($EOLS) ) has provided an announcement. On July 7, 2026, Evolus entere...
07-08 21:28
Evolus Enters Into Exclusive Licensing And Distribution Agreement With IBSA To Develop And Commercialize Profhilo In US
Evolus, Inc. (NASDAQ:EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced it has entered into an exclusive licensing and distribution agreement with IBSA, a Swiss multinational pharmaceutical company, to develop and commercial...
07-08 21:03
美股大行评级 | 花旗维持美光科技"买入"评级！目标价从840美元升至1200美元
今日重点评级关注：Chardan Capital：维持SAB Biotherapeutics"买入"评级，目标价从14美元升至16美元；Northland Capital Markets：维持Applied Digital"跑赢大市"评级，目标价从56美元升至82美元
06-18 19:08
BTIG Reiterates Buy on Evolus, Maintains $13 Price Target
BTIG analyst Sam Eiber reiterates Evolus (NASDAQ:EOLS) with a Buy and maintains $13 price target.
06-17 18:04
Evolus Shareholders Elect Directors and Ratify Key Proposals
Evolus ( ($EOLS) ) has provided an announcement. At its Annual Meeting of Stock...
06-13 06:14
Evolus Files Prospectus To Offer Up To $250M Of Securities
https://www.sec.gov/Archives/edgar/data/1570562/000157056226000071/evoluss-32026.htm
06-06 04:51
Shares of pharmaceutical companies are trading higher as investors rotate out of chips stocks and move into non-tech industries.
Shares of pharmaceutical companies are trading higher as investors rotate out o...
06-05 02:13
